The goals of many many continuous medical education & professional development are to acquire & retain knowledge that will enhance clinical practice & patients outcomes. This is like self-assessment survey particularly anesthesiologists, Intensivists & primary cardiologists, related to current guidelines & clinical trial data on the use of antiplatelet therapy.

Which is near ideal Antiplatelet agent for the post-ACS and why?